Principal Investigator(s)
David Ho, Clyde '56 and Helen Wu Professor of Medicine
Description: Dr. David Ho will lead an effort aimed at developing monoclonal antibodies, molecules that can bind to the surface of the coronavirus and neutralize the infectivity of the virus. His team will try to isolate antibodies from blood cells of patients who no longer have the virus and have recovered from 2019-nCoV infection. Then they will engineer the virus-neutralizing antibodies further to optimize their potency against 2019-nCoV. The most promising antibodies will be tested against actual coronavirus in the lab as well as in animal models.
If you are working on this project and would like to submit further information or feedback for this page, please click here.
